{"layout":"Indicator","sdg_goal":"3","goal_number":"3","indicator_number":"3.b.1","indicator_sort_order":"03-bb-01","permalink":"/3-b-1/","reporting_status":"complete","published":true,"data_non_statistical":false,"national_indicator_available":"Coverage of DTP (diphtheria, tetanus and pertussis) containing vaccine at school entrance <br> Coverage of HPV containing vaccine of 15 years old girls <br> Coverage of measles containing vaccine at school entrance <br> Coverage of pneumococcal conjugate vaccine at school entrance","comparison_sdg":"The time series are compliant with the four listed sub-indicators in the global metadata.","goal_meta_national_link":"https://g205sdgs.github.io/sdg-indicators/public/MetaDe/3.b.1.pdf","goal_meta_national_link_text":"National metadata","indicator_name":"Proportion of the target population covered by all vaccines included in their national programme","target_name":"Forschung und Entwicklung zu Impfstoffen und Medikamenten f\u00fcr \u00fcbertragbare und nicht\u00fcbertragbare Krankheiten, von denen haupts\u00e4chlich Entwicklungsl\u00e4nder betroffen sind, unterst\u00fctzen, den Zugang zu bezahlbaren unentbehrlichen Arzneimitteln und Impfstoffen gew\u00e4hrleisten, im Einklang mit der Erkl\u00e4rung von Doha \u00fcber das TRIPS-\u00dcbereinkommen und die \u00f6ffentliche Gesundheit, die das Recht der Entwicklungsl\u00e4nder bekr\u00e4ftigt, die Bestimmungen in dem \u00dcbereinkommen \u00fcber handelsbezogene Aspekte der Rechte des geistigen Eigentums \u00fcber Flexibilit\u00e4ten zum Schutz der \u00f6ffentlichen Gesundheit voll auszusch\u00f6pfen, und insbesondere den Zugang zu Medikamenten f\u00fcr alle zu gew\u00e4hrleisten","target_id":"3.b","un_designated_tier":"<a href=\"https://unstats.un.org/sdgs/iaeg-sdgs/tier-classification/\" title=\"Click here for more information on the UN tier classification.\">Tier I</a>","un_custodian_agency":"World Health Organization (WHO)<br>United Nations International Children's Fund (UNICEF)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"United Nations Sustainable Development Goals Metadata","source_active_1":true,"source_organisation_1":"Robert Koch Institute (RKI)","source_organisation_logo_1":"<a href=\"https://www.rki.de/DE/Home/homepage_node.html;jsessionid=897A9328BDF1782EBE1DD1059F3E66E5.2_cid298\"><img src=\"https://g205sdgs.github.io/sdg-indicators/public/OrgImgEn/rki.png\" alt=\"Logo rki\" style=\"height:60px; width:148px\" /></a>","source_url_1":"https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2018/Ausgaben/16_18.html","source_url_text_1":"Epidemiological Bulletin 16/2018 (only available in German)","source_url_1b":"https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2018/Ausgaben/01_18.pdf","source_url_text_1b":"Epidemiological Bulletin 1/2018","source_active_2":true,"source_organisation_2":"The Information System of the Federal Health Monitoring","source_organisation_logo_2":"<a href=\"http://www.gbe-bund.de/gbe10/pkg_isgbe5.prc_isgbe?p_uid=gast&p_aid=50815950&p_sprache=D\"><img src=\"https://g205sdgs.github.io/sdg-indicators/public/OrgImgDe/gbe.png\" alt=\"Logo gbe\" style=\"height:60px; width:148px\"/></a>","source_url_2":"http://www.gbe-bund.de/gbe10/I?I=831:27110398E","source_url_text_2":"Federal Health Monitoring System, table: \"vaccination coverage of children presenting their vaccination card at school entry health examinations\"","source_active_3":false,"source_active_4":false,"source_active_5":false,"source_active_6":false,"data_keywords":"Indikator 3.b.1, TP-Impfquote zum Schuleintritt, HPV-Impfquote bei 15-j\u00e4hrigen M\u00e4dchen, Masern-Impfquote zum Schuleintritt, Pneumokokken-Impfquote zum Schuleintritt, Weltgesundheitsorganisation (WHO), Kinderhilfswerk der Vereinten Nationen (UNICEF), Rober","data_show_map":false,"data_start_values":null,"computation_units":"Percentage (%)","copyright":"&copy; Federal Statistical Office (Destatis), 2020","data_footnote":null,"graph_title":null,"graph_type":"line","graph_min_value":null,"graph_max_value":null,"previous":"3-a-1","next":"3-b-2","national_geographical_coverage":"Germany","national_data_update_url_text":"2019-09-18: see changes on GitHub","national_data_update_url":"https://github.com/G205SDGs/sdg-data/commit/95825e1cce7cd7f207c4830a718d95b1b2432339","national_metadata_update_url_text":"2020-07-14: see changes on GitHub","national_metadata_update_url":"https://github.com/G205SDGs/sdg-data/commit/d0733ca00fc99a18095e7a09a51bf3773a048033","page_content":"\n","indicator":"3.b.1","language":"en","target":"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","goal_meta_2_link_text":null,"goal_meta_3_link_text":null}